74 related articles for article (PubMed ID: 8869067)
1. New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.
Patutina OA; Mironova NL; Vlassov VV; Zenkova MA
Acta Naturae; 2009 Jul; 1(2):44-60. PubMed ID: 22649602
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.
Liu Y; Wang Q; Kleinschmidt-DeMasters BK; Franzusoff A; Ng KY; Lillehei KO
J Neurooncol; 2007 Jan; 81(2):149-62. PubMed ID: 16941073
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for brain tumors.
Bansal K; Engelhard HH
Curr Oncol Rep; 2000 Sep; 2(5):463-72. PubMed ID: 11122879
[TBL] [Abstract][Full Text] [Related]
4. Genetic basis of intramedullary spinal cord tumors and therapeutic implications.
Parsa AT; Fiore AJ; McCormick PC; Bruce JN
J Neurooncol; 2000 May; 47(3):239-51. PubMed ID: 11016741
[TBL] [Abstract][Full Text] [Related]
5. Selective transvascular delivery of oligodeoxynucleotides to experimental brain tumors.
Koga H; Inamura T; Ikezaki K; Samoto K; Matsukado K; Fukui M
J Neurooncol; 1999 Jun; 43(2):143-51. PubMed ID: 10533726
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and p53 expression in human gliomas.
Sipos L; Szegedi Z; Fedorcsák I; Afra D; Szende B
Pathol Oncol Res; 1998; 4(4):267-70. PubMed ID: 9887356
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
8. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
Citro G; Perrotti D; Cucco C; D'Agnano I; Sacchi A; Zupi G; Calabretta B
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7031-5. PubMed ID: 1495997
[TBL] [Abstract][Full Text] [Related]
10. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides for central nervous system tumors.
Hall WA; Flores EP; Low WC
Neurosurgery; 1996 Feb; 38(2):376-83. PubMed ID: 8869067
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]